deltatrials
Completed PHASE3 NCT00002528

Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer

Surgical Therapy With or Without Axillary Node Clearance for Breast Cancer in the Elderly Who Receive Adjuvant Therapy With Tamoxifen.

Sponsor: ETOP IBCSG Partners Foundation

Conditions Breast Cancer
Interventions Axillary clearance conventional surgery radiation therapy tamoxifen citrate
Updated 7 times since 2017 Last updated: Apr 3, 2013 Started: May 31, 1993 Primary completion: Dec 31, 2002 Completion: Aug 31, 2010

Listed as NCT00002528, this PHASE3 trial focuses on Breast Cancer and remains completed. Sponsored by ETOP IBCSG Partners Foundation, it has been updated 7 times since 1993, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Oct 2022 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jan 2021 — Oct 2022 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

May 1993

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • ETOP IBCSG Partners Foundation
Data source: ETOP IBCSG Partners Foundation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia, Auckland, New Zealand, Aviano, Italy, Basel, Switzerland, Bern, Switzerland, Brescia, Italy, Budapest, Hungary, Cape Town, South Africa, Gorizia, Italy, Gothenburg (Goteborg), Sweden and 11 more location s